Anixa Biosciences Inc. (NASDAQ: ANIX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ANIXA BIOSCIENCES INC.

Anixa Biosciences Inc. (NASDAQ: ANIX)
Listen to this Section


$2.52
-0.1000 ( -3.82% ) 56.2K

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Market Data


Open $2.52
Previous Close $2.62
Volume 56.2K
Market Cap $84.49M
Day Range $2.50 - $2.70
52 Week Range $2.44 - $5.46
Shares Outstanding 33.53M
Change % -3.82%
Net Change ▼ -0.1000
Insider Ownership -0.11%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year1983
CountryUnited States

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 21, 2025
4 Insider transactions 1 Jul 15, 2025
4 Insider transactions 1 Jul 14, 2025
schedule Other 1 Jun 06, 2025
4 Insider transactions 1 Jun 05, 2025

Latest News


× Before browsing our site, please accept our cookies policy